Special Situations Digest #21

An activist group holding 11.7% of the Series A Preferred Stock of Power REIT (PW), a real estate investment trust focused on controlled-environment agriculture and renewable energy, notified the board of its failure to implement the election of two preferred-stockholder trustees to escalate a board-seat dispute. The group beneficially owns 39,281 shares of the 336,944 Series A shares outstanding and shares voting power solely on matters under Section 8 of the Articles Supplementary. This June 26, 2026, amendment to the original February filing includes a formal notice to the Board of Trustees regarding the failure to implement the stockholder election. The filing signals that the dispute has moved past negotiation into a compliance-enforcement phase, with the next observable being whether the board capitulates or the group seeks judicial relief to compel the election.

A group consisting of Moringa Sponsor, LP, Moringa Partners Ltd. and Ilan Levin reported a 10.6% stake in Silexion Therapeutics Corp (SLXN) while disputing the validity of recent share issuances. The amended Schedule 13D reports 45,000 shares issued on September 15, 2025 upon conversion of $1.8 million of outstanding note amount, 92,500 shares issued on May 14, 2026 upon conversion of $0.4 million, and 60,819 shares issued on June 14, 2026 upon conversion of $0.4 million. Moringa Sponsor expressly disputes the validity of those issuances and does not concede beneficial ownership of those shares. The challenge creates uncertainty over the reported beneficial ownership and may lead to further dispute over the conversion shares.

A strategic investor (CU Medical System) increased its stake in the KOSDAQ-listed company Vistos Co., Ltd. (419540.KQ) to 49.22% with the stated intent of influencing management. CU Medical System added 1,359,751 shares through a third-party allotment capital increase that settled June 18, 2026, raising its holding from 34.20% to 49.22% and total voting shares outstanding to 5,958,253. This DART large-shareholding filing is the Korean equivalent of a US 13D and clears the shareholder to influence management and board matters. The 49.22% position leaves CU Medical just below outright majority control, creating an overhang around any further accumulation or control consolidation steps.

A controlling group, HunamData Ltd., declared a management-control influence purpose at PeopleBio Co., Ltd. (304840.KQ), signaling an activist turn for the KOSDAQ-listed developer of neurodegenerative disease tests while facing a potential forced-sale overhang. The group holds a 9.02% voting interest, with the balance of its 57.82% position represented by convertible bonds. A June 24 amendment disclosed new agreements signed June 19 that increased the group's pledged CB position to 35.37% of total shares. This filing serves as the Korean equivalent of a US 13D, clearing the group to push for board and capital-structure changes. The absence of disclosed extensions for three CB pledge facilities covering 11.9 million shares that reached their June 11 maturity creates a potential forced-sale overhang if lenders enforce against the position.

An activist group (S.H. Healthcare Investment Fund No. 1) reported a 23% stake in NGenebio Co., Ltd. (354200.KQ), a biotechnology company focused on molecular diagnostics, to influence management control. The filing updates the group’s holding of 2,055,257 shares following a 3:1 reverse stock split that became effective on June 25, 2026. While the ownership percentage remains unchanged at 23%, the group cited all ten statutory grounds for influencing management under the Enforcement Decree of the Capital Markets Act. The reporting entity is a private investment fund whose largest limited partner is KCJ Partners, which holds a 77.51% interest and is ultimately controlled by Jin Ki-cheon. This large shareholding report is the Korean equivalent of a US 13D and clears the filer to push for board changes. The reduced post-split share count of 8.94 million shares increases the potential for rapid control shifts via additional accumulation or block trades.

An activist investor (MTM Capital Co., Ltd.) disclosed an increased 9.55% stake in Chiiki Shinbunsha Co., Ltd. (2164.T), a Japanese publisher of regional community newspapers, with a stated purpose of making important proposals. MTM Capital increased its position from 5.09% through market purchases between May 13 and June 18, 2026, including 355,000 shares acquired on-market on June 18. MTM Capital holds 800,400 shares out of 8,381,728 issued shares. The filing is a Japanese large-shareholding report with significant-proposal intent.

The controlling shareholder group of Aroot Co., Ltd. (096690.KQ), a KOSDAQ-listed company, increased its stake to 23.76% and filed a management-control disclosure to signal its intent to influence corporate strategy. Largest shareholder Choi Jung Im and concert parties raised their combined holding from 19.07% through open-market purchases and the acquisition of call options on convertible bonds from entities including Curious Holdings and Crypto Growth No. 1. The filing follows the 'purpose of influencing management control' provision of Korea's Capital Markets Act. One concert party member, Daol AM, has 106,948 shares pledged as collateral to Cham Savings Bank under an agreement maturing July 14, 2026. This Korean equivalent of a US 13D allows the group to push for board changes without triggering a mandatory tender offer, while the 2.46% of shares pledged as collateral creates a structural overhang.

An activist group (Tricon No. 1 Investment Association) reported a 23.08% stake in the KOSPI-listed company Playgram (009810.KS) for the purpose of influencing management control. The filing marks an escalation from a passive holding to an active posture, with the group's stake percentage increasing from 22.45% following a share consolidation. Approximately 17.42% of the company's outstanding shares are currently pledged as collateral under a loan agreement with MDS Intelligence. A related-party share transfer agreement is scheduled to move 121,724 shares to Tricon Holdings by August 31, 2026. This management-control filing is the Korean equivalent of a US 13D and clears the filer to push for board changes, though the significant collateral pledge creates a structural overhang.

Two activist shareholders are facing a formal investigation by Muraki Co., Ltd. (7477.T), a Tokyo-listed company targeting electric vehicle-related growth areas, to determine if they are acting in concert and should be subject to the company's poison pill. Ikuyo Co., Ltd. holds a 17.01% stake and Blue Goats Capital Co., Ltd. holds 7.01%, and both entities submitted near-identical proposals in April 2026 to nominate six overlapping director candidates and abolish the company's takeover defense policy. On June 23, 2026, the board referred the matter to an independent committee to evaluate whether these actions constitute coordinated conduct under the rights plan. A determination of coordinated conduct would trigger the 20% threshold of the takeover defense policy, forcing the group to either comply with formal procedures or face dilution through board-deployed countermeasures.

An activist investor (Howard Todd Horberg) acquired a 5.61% stake in Equus Total Return, Inc. (EQS), a closed-end investment fund holding oil and gas and fire suppression assets, to demand a strategic review and compensation reforms. The 13D filing and open letter cite a 65% decline in net asset value over two years and executive compensation totaling 22% of the company’s non-affiliate market cap. Specific demands include suspending automatic salary escalators and engaging an independent financial advisor to evaluate a merger with or acquisition by an operating company. The fund, which received a going-concern warning in its 2025 audit, has reported five consecutive years of net investment losses and paid no dividend since 2009. This challenge marks the first public activism at the fund in fifteen years and precedes a June 30, 2026, annual meeting. The vote serves as an immediate governance flashpoint where the outcome hinges on whether the 22.71% second-largest holder aligns with management’s ~30.5% insider block or the activist.